Fang Jian-Xiu, Chen Xiao-Yan, Yang Qing-Mei, Xue Meng-Hua
Department of Ultrasound, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, 030032, People's Republic of China.
Int J Gen Med. 2021 May 18;14:1911-1917. doi: 10.2147/IJGM.S311420. eCollection 2021.
Glomerulosclerosis and tubulointerstitial fibrosis are associated with lower renal parenchymal resilience. The purpose of this study is to determine the factors influencing renal resilience in patients with diabetic nephropathy (DN).
We recruited 56 healthy volunteers and 187 patients with DN. All the participants were evaluated using shear-wave elastography (SWE), and the size of their kidneys and Young's modulus values for the parenchyma were recorded. A total of 187 patients with DN are allocated to three groups according to their urinary albumin-to-creatinine ratio: normoalbuminuric (<30 mg/g creatinine), microalbuminuric (30-300 mg/g), and macroalbuminuric (≥300 mg/g) groups. Renal resilience is compared between the stages of diabetic nephropathy and the healthy control group, and the factors affecting the stiffiness of the renal parenchyma in DN are analyzed.
The renal parenchyma is harder in participants with DN than in healthy participants ( < 0.001), and the stiffiness increases with the progression of the disease ( < 0.001). Multivariate logistic regression analysis shows that disease stage (β = 0.789, < 0.001), duration of diabetes (β = 0.028, < 0.001), and serum creatinine (SCr) concentration (β = 0.001, < 0.001) influence the stiffiness of the renal parenchyma.
We show that SWE can be used to measure changes in the stiffiness of the renal parenchyma in patients with DN. Furthermore, Young's modulus of the renal parenchyma is related to the duration of diabetes, urinary albumin excretion, and SCr concentration. Thus, SWE can be used to objectively and non-invasively stage DN.
肾小球硬化和肾小管间质纤维化与肾实质弹性降低有关。本研究旨在确定影响糖尿病肾病(DN)患者肾弹性的因素。
我们招募了56名健康志愿者和187名DN患者。所有参与者均采用剪切波弹性成像(SWE)进行评估,并记录其肾脏大小和肾实质的杨氏模量值。根据尿白蛋白与肌酐比值,将187名DN患者分为三组:正常白蛋白尿组(<30mg/g肌酐)、微量白蛋白尿组(30 - 300mg/g)和大量白蛋白尿组(≥300mg/g)。比较糖尿病肾病各阶段与健康对照组之间的肾弹性,并分析影响DN患者肾实质硬度的因素。
DN患者的肾实质比健康参与者更硬(<0.001),且硬度随疾病进展而增加(<0.001)。多因素逻辑回归分析表明,疾病阶段(β = 0.789,<0.001)、糖尿病病程(β = 0.028,<0.001)和血清肌酐(SCr)浓度(β = 0.001,<0.001)影响肾实质硬度。
我们表明SWE可用于测量DN患者肾实质硬度的变化。此外,肾实质的杨氏模量与糖尿病病程、尿白蛋白排泄和SCr浓度有关。因此,SWE可用于客观、无创地对DN进行分期。